Stereotactic body radiation therapy use for high risk prostate cancer in the United States

被引：3
|
作者：
Patel, Sagar A. [1 ]
Switchenko, Jeffrey M. [2 ]
Kishan, Amar U. [3 ]
Jani, Ashesh B. [1 ]
Royce, Trevor J. [4 ]
Fischer-Valuck, Benjamin W. [1 ]
机构：
[1] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA
[4] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2021年 / 24卷 / 02期
关键词：
ANDROGEN SUPPRESSION;
D O I：
10.1038/s41391-020-00300-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：578 / 581
页数：4
相关论文
共 50 条
  • [11] Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?
    Gonzalez-Motta, Alejandro
    Roach, Mack, III
    PRACTICAL RADIATION ONCOLOGY, 2018, 8 (03) : 185 - 202
  • [12] The Early Result of Stereotactic Body Radiation Therapy Boost for High-Risk Localized Prostate Cancer
    Lin, Y.
    Kuei-Li, L.
    Li-Ching, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S373 - S374
  • [13] Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis
    Malouff, Timothy D.
    Stross, William C.
    Seneviratne, Danushka S.
    Waddle, Mark R.
    May, Byron C.
    Buskirk, Steven J.
    Tzou, Katherine S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (02) : 349 - 355
  • [14] Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis
    Timothy D. Malouff
    William C. Stross
    Danushka S. Seneviratne
    Mark R. Waddle
    Byron C. May
    Steven J. Buskirk
    Katherine S. Tzou
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 349 - 355
  • [15] Stereotactic body radiation therapy with androgen deprivation therapy for unfavorable-risk prostate cancer
    Patel, Sagar Anil
    Switchenko, Jeffrey M.
    Zhang, Chao
    Rose, Brent Shane
    Fischer-Valuck, Benjamin Walker
    Jani, Ashesh B.
    Chen, Ronald C.
    Royce, Trevor Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [16] Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients
    Katz, A.
    Kang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E250 - E250
  • [17] Utilization of androgen deprivation therapy (ADT) and stereotactic body radiation therapy (SBRT) for localized prostate cancer (PC) in the United States (US)
    Royce, Trevor Joseph
    Switchenko, Jeffrey M.
    Zhang, Chao
    Spratt, Daniel Eidelberg
    Chen, Ronald C.
    Jani, Ashesh B.
    Patel, Sagar Anil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [18] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
    Ju, Andrew W.
    Wang, Hongkun
    Oermann, Eric K.
    Sherer, Benjamin A.
    Uhm, Sunghae
    Chen, Viola J.
    Pendharkar, Arjun V.
    Hanscom, Heather N.
    Kim, Joy S.
    Lei, Siyuan
    Suy, Simeng
    Lynch, John H.
    Dritschilo, Anatoly
    Collins, Sean P.
    RADIATION ONCOLOGY, 2013, 8
  • [19] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
    Andrew W Ju
    Hongkun Wang
    Eric K Oermann
    Benjamin A Sherer
    Sunghae Uhm
    Viola J Chen
    Arjun V Pendharkar
    Heather N Hanscom
    Joy S Kim
    Siyuan Lei
    Simeng Suy
    John H Lynch
    Anatoly Dritschilo
    Sean P Collins
    Radiation Oncology, 8
  • [20] Use of stereotactic body radiation therapy for oligometastatic recurrent prostate cancer: A systematic review
    Vilela, Ricardo Alencar
    Navarro, Natassia Ferreira
    Faria, Edison Tostes
    Ferreira, Elaine Barros
    Ruzza, Rachel Zomer
    Gadia, Rafael
    Silva Guerra, Eliete Neves
    Diniz dos Reis, Paula Elaine
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2018, 62 (05) : 692 - 706
12345